APA (7th ed.) Citation

X, G., L, L., L, Z., Y, Z., T, N., & Z, Y. (2026). Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma. Targeted oncology, 21(2), 167. https://doi.org/10.1007/s11523-026-01199-z

Chicago Style (17th ed.) Citation

X, Gan, Li L, Zhang L, Zheng Y, Niu T, and Yu Z. "Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma." Targeted Oncology 21, no. 2 (2026): 167. https://doi.org/10.1007/s11523-026-01199-z.

MLA (9th ed.) Citation

X, Gan, et al. "Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple Myeloma." Targeted Oncology, vol. 21, no. 2, 2026, p. 167, https://doi.org/10.1007/s11523-026-01199-z.